Results 151 to 160 of about 146,499 (323)

Two‐Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison [PDF]

open access: bronze
Yue‐Xi Chen   +9 more
openalex   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Phytochemical-Based Strategies for Lung Cancer: Clinical Insights Into Pleiotropic Molecular Signaling and Therapeutic Roles. [PDF]

open access: yesPhytother Res
Lung cancer (LC) remains the leading cause of global cancer‐related death. Phytochemicals from medicinal plants are increasingly being considered as potential LC treatment agents due to their multi‐targeted action, safety, and accessibility. These have anticancer properties by regulating key molecular signaling pathways.
Islam MR   +14 more
europepmc   +2 more sources

International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I [PDF]

open access: bronze, 2018
Luís Eduardo Coelho Andrade   +10 more
openalex   +1 more source

Accessing New Phenanthroline–Oxazine Scaffolds as Copper‐Dependent DNA Damaging Probes

open access: yesChemBioChem, Volume 27, Issue 8, 28 April 2026.
New phenanthroline–oxazine ligands derived from natural amino acids are synthesized through an optimized, predictive strategy. When coordinated to copper, these scaffolds display tunable DNA binding, groove selectivity, and oxidative cleavage activity, revealing clear structure activity relationships and expanding the toolbox of copper‐dependent ...
Rebecca Lynn   +10 more
wiley   +1 more source

Anthraquinones from Neonauclea calycina and Their Inhibitory Activity against DNA Topoisomerase II.

open access: bronze, 1998
Hideki Tosa   +9 more
openalex   +2 more sources

A case of juvenile localized scleroderma with anti-topoisomerase I antibody [PDF]

open access: gold, 2019
Kyoko Shimizu   +3 more
openalex   +1 more source

Elucidating the Solvent‐Dependent Solvation and Structural Stability of Irinotecan: A Molecular Simulation Study

open access: yesChemPhysChem, Volume 27, Issue 8, 28 April 2026.
The solvation preference of irinotecan is governed by a competition between cavity formation and electrostatic stabilization. Computations reveal that the high cost of breaking water's hydrogen bond network outweighs its electrostatic benefits. In contrast, polar aprotic solvents (e.g., pyridine) offer an optimal thermodynamic balance, providing strong
Martin M. Bitabo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy